Clinical research organisation (CRO) ICON has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes ICON the first CRO to completely integrate this ...

Adoption allows ICON to take full advantage of the Medidata "Data Experience," leveraging AI to unify data sources, standardize outputs, and reduce reconciliation efforts NEW YORK, March 20, ...

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired ...

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today ...

LEO Pharma has partnered with clinical research organisation ICON to advance trial execution within medical dermatology. LEO said the deal will enable it to scale up its clinical trial operations in a ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces that it has been selected by the US Biomedical Advanced ...

Pfizer is reducing substantially the number of external service providers it uses to execute its clinical trials by entering into five-year strategic alliances with Parexel and ICON. Pfizer is ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces the release of its next generation Clinical Trial ...

Irish contract research organisation (CRO) ICON has added global heft to its US-based staffing business by acquiring DOCS International, a European clinical research staffing organisation based in the ...